• Journal Article

Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatmetn of schizophrenia in acute care inpatient settings

Citation

Mladsi, D., Grogg, A., Irish, W., Lopez, R., Degen, K., Swann, A., & Nimsch, C. (2004). Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatmetn of schizophrenia in acute care inpatient settings. Current Medical Research and Opinion, 20(12)(ISSN 0300-7995), 1883 - 1952.

Abstract